mutations supplied The truth that, as explained below, CLL therapy relies around the existence or absence of such mutations. The present consensus is always that, apart from clonal mutations, subclonal mutations with a variant allelic frequency starting from 5 to 10% (and as a consequence beneath the threshold of detection by typical molecular meth